Recombinant Human Oncostatin-M(OSM) Market Report – Research, Industry Analysis Reports and Market Demands

Global Recombinant Human Oncostatin-M(OSM) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Recombinant Human Oncostatin-M(OSM) Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity＜95%
- 1.3.3 Purity ≥95%
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Recombinant Human Oncostatin-M(OSM) Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 University
- 1.4.3 Research Center
1.5 Global Recombinant Human Oncostatin-M(OSM) Market Size & Forecast
- 1.5.1 Global Recombinant Human Oncostatin-M(OSM) Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Recombinant Human Oncostatin-M(OSM) Sales Quantity (2020-2031)
- 1.5.3 Global Recombinant Human Oncostatin-M(OSM) Average Price (2020-2031)

2 Manufacturers Profiles

3 Competitive Environment: Recombinant Human Oncostatin-M(OSM) by Manufacturer

3.1 Global Recombinant Human Oncostatin-M(OSM) Sales Quantity by Manufacturer (2020-2025)
3.2 Global Recombinant Human Oncostatin-M(OSM) Revenue by Manufacturer (2020-2025)
3.3 Global Recombinant Human Oncostatin-M(OSM) Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Recombinant Human Oncostatin-M(OSM) by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Recombinant Human Oncostatin-M(OSM) Manufacturer Market Share in 2024
- 3.4.3 Top 6 Recombinant Human Oncostatin-M(OSM) Manufacturer Market Share in 2024
3.5 Recombinant Human Oncostatin-M(OSM) Market: Overall Company Footprint Analysis
- 3.5.1 Recombinant Human Oncostatin-M(OSM) Market: Region Footprint
- 3.5.2 Recombinant Human Oncostatin-M(OSM) Market: Company Product Type Footprint
- 3.5.3 Recombinant Human Oncostatin-M(OSM) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Recombinant Human Oncostatin-M(OSM) Market Size by Region
- 4.1.1 Global Recombinant Human Oncostatin-M(OSM) Sales Quantity by Region (2020-2031)
- 4.1.2 Global Recombinant Human Oncostatin-M(OSM) Consumption Value by Region (2020-2031)
- 4.1.3 Global Recombinant Human Oncostatin-M(OSM) Average Price by Region (2020-2031)
4.2 North America Recombinant Human Oncostatin-M(OSM) Consumption Value (2020-2031)
4.3 Europe Recombinant Human Oncostatin-M(OSM) Consumption Value (2020-2031)
4.4 Asia-Pacific Recombinant Human Oncostatin-M(OSM) Consumption Value (2020-2031)
4.5 South America Recombinant Human Oncostatin-M(OSM) Consumption Value (2020-2031)
4.6 Middle East & Africa Recombinant Human Oncostatin-M(OSM) Consumption Value (2020-2031)

5 Market Segment by Type

5.1 Global Recombinant Human Oncostatin-M(OSM) Sales Quantity by Type (2020-2031)
5.2 Global Recombinant Human Oncostatin-M(OSM) Consumption Value by Type (2020-2031)
5.3 Global Recombinant Human Oncostatin-M(OSM) Average Price by Type (2020-2031)

6 Market Segment by Application

6.1 Global Recombinant Human Oncostatin-M(OSM) Sales Quantity by Application (2020-2031)
6.2 Global Recombinant Human Oncostatin-M(OSM) Consumption Value by Application (2020-2031)
6.3 Global Recombinant Human Oncostatin-M(OSM) Average Price by Application (2020-2031)

7 North America

7.1 North America Recombinant Human Oncostatin-M(OSM) Sales Quantity by Type (2020-2031)
7.2 North America Recombinant Human Oncostatin-M(OSM) Sales Quantity by Application (2020-2031)
7.3 North America Recombinant Human Oncostatin-M(OSM) Market Size by Country
- 7.3.1 North America Recombinant Human Oncostatin-M(OSM) Sales Quantity by Country (2020-2031)
- 7.3.2 North America Recombinant Human Oncostatin-M(OSM) Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

8.1 Europe Recombinant Human Oncostatin-M(OSM) Sales Quantity by Type (2020-2031)
8.2 Europe Recombinant Human Oncostatin-M(OSM) Sales Quantity by Application (2020-2031)
8.3 Europe Recombinant Human Oncostatin-M(OSM) Market Size by Country
- 8.3.1 Europe Recombinant Human Oncostatin-M(OSM) Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Recombinant Human Oncostatin-M(OSM) Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

9.1 Asia-Pacific Recombinant Human Oncostatin-M(OSM) Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Recombinant Human Oncostatin-M(OSM) Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Recombinant Human Oncostatin-M(OSM) Market Size by Region
- 9.3.1 Asia-Pacific Recombinant Human Oncostatin-M(OSM) Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Recombinant Human Oncostatin-M(OSM) Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

10.1 South America Recombinant Human Oncostatin-M(OSM) Sales Quantity by Type (2020-2031)
10.2 South America Recombinant Human Oncostatin-M(OSM) Sales Quantity by Application (2020-2031)
10.3 South America Recombinant Human Oncostatin-M(OSM) Market Size by Country
- 10.3.1 South America Recombinant Human Oncostatin-M(OSM) Sales Quantity by Country (2020-2031)
- 10.3.2 South America Recombinant Human Oncostatin-M(OSM) Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

11.1 Middle East & Africa Recombinant Human Oncostatin-M(OSM) Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Recombinant Human Oncostatin-M(OSM) Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Recombinant Human Oncostatin-M(OSM) Market Size by Country
- 11.3.1 Middle East & Africa Recombinant Human Oncostatin-M(OSM) Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Recombinant Human Oncostatin-M(OSM) Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

12.1 Recombinant Human Oncostatin-M(OSM) Market Drivers
12.2 Recombinant Human Oncostatin-M(OSM) Market Restraints
12.3 Recombinant Human Oncostatin-M(OSM) Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Recombinant Human Oncostatin-M(OSM) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Recombinant Human Oncostatin-M(OSM)
13.3 Recombinant Human Oncostatin-M(OSM) Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Recombinant Human Oncostatin-M(OSM) Typical Distributors
14.3 Recombinant Human Oncostatin-M(OSM) Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Recombinant Human Oncostatin-M(OSM) market size was valued at US$ 110 million in 2024 and is forecast to a readjusted size of USD 201 million by 2031 with a CAGR of 8.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Oncostatin M (OSM) is a growth differentiation factor involved in the regulation of neurogenesis, osteogenesis, and hematopoiesis. It stimulates the proliferation of fibroblasts, smooth muscle cells, and Kaposi's sarcoma cells, but inhibits the growth of some normal and tumor cell lines. It also promotes the release of cytokines (such as IL-6, GM-CSF, and g-CSF) from endothelial cells and enhances the expression of low-density lipoprotein receptors in hepatoma cells. OSM is produced by activated T cells, monocytes, and Kaposi's sarcoma cells and has stimulatory and inhibitory effects on cell proliferation.
This report is a detailed and comprehensive analysis for global Recombinant Human Oncostatin-M(OSM) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Recombinant Human Oncostatin-M(OSM) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human Oncostatin-M(OSM) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human Oncostatin-M(OSM) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Recombinant Human Oncostatin-M(OSM) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Recombinant Human Oncostatin-M(OSM)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Recombinant Human Oncostatin-M(OSM) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Recombinant Human Oncostatin-M(OSM) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity＜95%
Purity ≥95%
Market segment by Application
University
Research Center
Major players covered
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
ENZO
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Oncostatin-M(OSM) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Oncostatin-M(OSM), with price, sales quantity, revenue, and global market share of Recombinant Human Oncostatin-M(OSM) from 2020 to 2025.
Chapter 3, the Recombinant Human Oncostatin-M(OSM) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Oncostatin-M(OSM) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Recombinant Human Oncostatin-M(OSM) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Oncostatin-M(OSM).
Chapter 14 and 15, to describe Recombinant Human Oncostatin-M(OSM) sales channel, distributors, customers, research findings and conclusion.

Buy now